Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ABT-335 (Choline Fenofibrate)Reverse Cholesterol Transport (RCT) Study

NCT00673881 is registered in ClinicalTrials.gov with Radiant Research as lead sponsor.

NCT NCT00673881
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00673881 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ABT-335 (Choline Fenofibrate)Reverse Cholesterol Transport (RCT) Study
Lead sponsor
Radiant Research
Phase
Phase 1/2
Overall status
Completed
Start date
March 31, 2008
Completion date
May 31, 2009
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dyslipidemia